Justice Clarence Thomas issued a scathing dissent Monday after the Supreme Court declined to hear a case challenging free speech rights around abortion clinics, suggesting he wants to revisit the matter after the court ended the federal constitutional right to abortion in 2022.
The big picture: The high court's move marked a loss for abortion opponents who claimed their First Amendment rights are violated by laws that limit demonstrations near clinics.
Elizabeth Holmes, the founder of failed blood-testing startup Theranos, must complete her 11-year prison sentence, after a U.S. appeals court on Monday upheld her conviction for defrauding investors.
The big picture: This was always a long-shot appeal, with Holmes' attorneys arguing that trial judge had made errors.
Denny's is temporarily adding an egg surcharge at some of its restaurants because of the nationwide egg shortage and increased prices, the chain confirmed to Axios Monday.
Why it matters: The bird flu has ravaged the nation's supply of eggs, leading to shortages and higher prices at grocery stores and restaurants.
Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food and Drug Administration has declared Novo Nordisk's blockbusters Ozempic and Wegovy are no longer in shortage.
Why it matters: The announcement on Friday effectively ends anFDA policy that allowed drug compounders to make less expensive off-brand versions of the semaglutide injections when the brand-name products are in short supply. And it may force patients to pay more to stay on their regimens.
Supplement makers, practitioners of alternative medicine and others in the wellness movement are hoping to capitalize on Robert F. Kennedy Jr.'s tenure as the nation's top health official.
Why it matters: Kennedy's interest in treating the root causes of chronic illnesses through lifestyle changes could elevate unregulated alternatives and risky pseudoscience while relegating diagnosis and treatment of disease to the back burner, critics warn.
Why it matters: The Trump administration has taken actions that undermine accessibility measures — critical for leveling the playing field for people with disabilities — as part of its efforts targeting diversity, equity, and inclusion efforts.
